PDF下载 ( 871 KB)
Journal of Gastroenterology and Hepatology｜PD-1抑制剂联合化疗较单纯化疗一线治疗可显著改善转移性或复发性胆管癌患者的中位无进展生存期
DOI: 10.3969/j.issn.1001-5256.2022.02.gwjpwzjj5
Journal of Gastroenterology and Hepatology｜Compared with chemotherapy alone as the first-line treatment, PD-1 inhibitor combined with chemotherapy can significantly improve the median progression-free survival time of patients with metastatic or recurrent cholangiocarcinoma
本文二维码
计量
- 文章访问数: 256
- HTML全文浏览量: 121
- PDF下载量: 34
- 被引次数: 0
下载:
